For 16 years, ISS has supported drug development in by matching clinical trials with qualified investigators. Each year we successfully place sites on nearly 250 studies for more than 80 sponsors and CROs in the United States, and we are excited to expand our reach to India in support of global clinical research
Chicago, IL (PRWEB) December 18, 2008
Excel Life Sciences (ELS), a U.S.-based, India-focused provider of comprehensive trial management services announces that it has formed a partnership with Chicago-based Investigator Support Services (ISS) to help biopharmaceutcal companies and CROs identify investigative sites in India for their clinical research studies.
ELS has one of the largest networks of investigative sites in India with over 1,000 investigators and 700 sites. Each site has undergone an extensive due diligence visit and review by ELS to determine its experience and capabilities before they are accepted into the ELS network, enabling ELS to find the most qualified investigative sites for customers. In three recent studies, sponsors selected 100%, 80% and 100% of sites recommended by ELS for the study.
"We are very excited to be partnering with ISS to help their customers identify appropriate investigative sites in India. We are confident that together we can help more companies enter into India and run successful, on-time clinical studies," said Dr. Vijai Kumar, President and Chief Medical Officer, Excel Life Sciences.
ISS represents 400 experienced sites with capabilities to conduct phase I-IV drug and device studies in all medical specialties.. All sites pass a quality review prior to inclusion in the ISS network and are further pre-qualified for individual studies based on protocol requirements. At no cost to industry sponsors and CROs, ISS quickly provides study related documents and contact information for the most appropriate investigators. Sponsors and CROs negotiate budgets and contracts with site personnel, make the final selection decision, and remit payment directly to participating sites.
"For 16 years, ISS has supported drug development in by matching clinical trials with qualified investigators. Each year we successfully place sites on nearly 250 studies for more than 80 sponsors and CROs in the United States, and we are excited to expand our reach to India in support of global clinical research," said Sarah Ebner, President, Investigator Support Services.
About Excel Life Sciences
Headquartered in Chicago, IL with offices in Boston, Raleigh-Durham, Washington DC, Hyderabad, Mumbai, New Delhi and 21 other locations across India, ELS is one of the most experienced and fastest growing trial management and site support organizations in India, offering customized clinical trial solutions including: regulatory consulting, preparations, submissions and query resolution; site identification and selection; patient recruitment and retention; training of all clinical research stakeholders; technology transfer; product licensing and more.
ELS has one of the most experienced and respected clinical operations teams in India with over 125 years of collective experience in conducting more than 350 global and domestic trials at hundreds of sites and with thousands of patients. ELS has also trained over 1,500 clinical research personnel in India. For more information visit: http://www.ExcelLifeSciences.com.
About Investigator Support Services
Investigator Support Services (ISS) supports industry sponsors and CROs, worldwide, by expediting site identification for phase I-IV studies across all therapeutic areas. At no cost to either the sponsor or CRO, ISS provides access to hundreds of experienced research sites, pre-qualified for US and global trials based on protocol requirements. Investigators join ISS at no charge and benefit from a continuous stream of new trials matched with their interests and capabilities. Sites remain independent and contract on a study-by-study basis, paying a percentage-based fee only upon selection and payment from the sponsor.
ISS also represents a healthcare call center specializing in patient recruitment and related clinical trial services. Multilingual nurse and lay operators, Interactive Voice Response System (IVRS), and Web-based screening tools pre-qualify callers according to study inclusion/exclusion criteria. Call center solutions include a full range of patient retention and compliance programs, fulfillment services, and custom-tailored data management and reporting options. For more information visit http://www.ResearchSite.net.